9.04% -0.0495

Oncolytics Biotech Inc (ONCY)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Oncolytics Biotech Inc-Aktie (ONCY)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
Operating Expenses	1.06% 9.379	9.281
Operating Income/Loss	1.06% -9.379	-9.281
Income/Loss From Continuing Operations Before Tax	-9.341	-
Income Tax Expense/Benefit	0.101	-
Net Income/Loss	2.15% -9.442	-9.243
Basic Average Shares	6.63% 119.74	112.29
Diluted Average Shares	6.63% 119.74	112.29
Basic Earnings Per Share	0.00% -0.08	-0.08
Diluted Earnings Per Share	0.00% -0.08	-0.08

OLMA

$6.58

4.22%

ZVRA

$9.94

3.21%

SLDB

$5.53

3.66%

AVTX

$11.27

6.16%

NVCT

$18.60

1.74%

WVE

$3.13

1.88%